SCHEMBL17375083

SCHEMBL17375083

C#Cc1ccccc1C(=O)O[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
TSHR P16473 6/20 0.35
LMNA P02545 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 2/20 0.33
CFTR P13569 1/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29019073 0.85 NPC1 (0.33) NPC1TSHRALDH1A1KDM4EL3MBTL1
SCHEMBL16004864 0.81 TSHR (0.50) NPC1TSHRLMNAALDH1A1HSD17B10
SCHEMBL498003 0.80 TSHR (0.55) TSHRLMNAALDH1A1HSD17B10CFTR
Potassium SCHEMBL30901224 0.79 TSHR (0.48) NPC1TSHRLMNAALDH1A1HSD17B10
SCHEMBL11092121 0.77 CES2 (0.52) NPC1LMNAALDH1A1POLBL3MBTL1
SCHEMBL28846633 0.77 NPC1 (0.43) NPC1TSHRLMNAALDH1A1HSD17B10
SCHEMBL15611971 0.76 SLC6A3 (0.51) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL19638940 0.76 TSHR (0.67) NPC1TSHRLMNAALDH1A1HSD17B10
SCHEMBL17607318 0.76 NPC1 (0.40) NPC1TSHRLMNAALDH1A1HSD17B10
SCHEMBL30778085 0.74 LMNA (0.62) NPC1TSHRLMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024027792-A1 PROTEIN KINASE DEGRADING AGENT, MEDICAMENT AND USE SHENZHEN NEWDEL BIOTECH CO., LTD. (CN) 2024-02-08 WO disclosed
WO-2015197028-A1 COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-12-30 WO disclosed